Terns Pharmaceuticals Inc. buy BiotechBee
Start price
22.06.24
/
50%
€6.85
Target price
30.04.26
€10.00
Performance (%)
2.92%
End price
08.09.24
€7.05
Summary
This prediction ended on 08.09.24 with a price of €7.05. The BUY prediction by BiotechBee finished with a performance of 2.92%. BiotechBee has a follow-up prediction for Terns Pharmaceuticals Inc. where he still thinks Terns Pharmaceuticals Inc. is a Buy. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Terns Pharmaceuticals Inc. | 20.423% | 20.423% |
iShares Core DAX® | 2.275% | 4.627% |
iShares Nasdaq 100 | 6.015% | 2.007% |
iShares Nikkei 225® | 4.456% | 3.598% |
iShares S&P 500 | 4.061% | 2.876% |
According to BiotechBee what are the pros and cons of Terns Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Terns Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 10,0
In the thread Trading Terns Pharmaceuticals Inc.
Buy beendet
Current prediction by BiotechBee for Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.05
08.09.24
08.09.24
€20.00
31.03.27
31.03.27
14.89%
12.09.24
12.09.24
Could be very worthwhile Investment >20% year
Stopped prediction by BiotechBee for Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.87
24.06.23
24.06.23
€18.00
31.12.25
31.12.25
-45.26%
01.10.23
01.10.23
Could be very worthwhile Investment >20% year